Toronto Dominion Bank’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History
Bought
Maintained
Sold
Other funds holding OACCW
AA
DAM
BGIM
WAM
LA
SCM
MCM
Toronto Dominion Bank's OACCW Position: Q1 2026 in Review
Toronto Dominion Bank increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 253% in Q1 2026, buying an estimated $97.1K and bringing the position to 173,200 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.
Toronto Dominion Bank first reported a position in OACCW in Q2 2025 and has held it in 4 quarters since. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.
- Toronto Dominion Bank held 173,200 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $130K as of Q1 2026.
- Toronto Dominion Bank bought 124,158 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $97.1K.
- Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1640 holding.
- Toronto Dominion Bank first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q2 2025 and has held it in 4 quarters since.
- 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.